We are live on ! Find out more
MD icon

Pediatrix Medical

214 hedge funds and large institutions have $1.25B invested in Pediatrix Medical in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

2% more funds holding

Funds holding: 209214 (+5)

4% more capital invested

Capital invested by funds: $1.2B → $1.25B (+$47.7M)

0.67% less ownership

Funds ownership: 101.56%100.88% (-0.67%)

58% less call options, than puts

Call options by funds: $684K | Put options by funds: $1.62M

Holders
214
Holders Change
+5
Holders Change %
+2.39%
% of All Funds
3.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
90
Reduced
58
Closed
28
Calls
$684K
Puts
$1.62M
Net Calls
-$932K
Net Calls Change
-$1.09M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$7.36M +$3.43M +226,374 +85%
Ameriprise
27
Ameriprise
Minnesota
$6.61M -$105K -6,922 -2%
ICM
28
Invenomic Capital Management
Massachusetts
$6.17M +$6.27M +413,923 New
Goldman Sachs
29
Goldman Sachs
New York
$5.77M +$99K +6,534 +2%
SGCIA
30
Smith Graham & Co Investment Advisors
Texas
$5.54M -$17.7K -1,167 -0.3%
AQR Capital Management
31
AQR Capital Management
Connecticut
$4.8M +$1.52M +100,411 +44%
BIP
32
Brandes Investment Partners
California
$4.29M +$2.44M +161,258 +128%
BA
33
Bridgewater Associates
Connecticut
$4.27M +$2.53M +166,920 +140%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$4.24M +$164K +10,854 +4%
ECM
35
ExodusPoint Capital Management
New York
$4.17M +$2.87M +189,124 +210%
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$3.91M +$1.51M +99,457 +61%
Millennium Management
37
Millennium Management
New York
$3.85M +$2.68M +177,071 +219%
Wells Fargo
38
Wells Fargo
California
$3.74M +$449K +29,662 +13%
Legal & General Group
39
Legal & General Group
United Kingdom
$3.61M -$112K -7,395 -3%
N
40
Nuveen
North Carolina
$3.23M -$477K -31,519 -13%
Federated Hermes
41
Federated Hermes
Pennsylvania
$3.15M -$522K -34,457 -14%
SEI Investments
42
SEI Investments
Pennsylvania
$2.97M +$729K +48,100 +32%
SDIC
43
South Dakota Investment Council
South Dakota
$2.77M +$208K +13,700 +8%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.54M -$351K -23,200 -12%
Axa
45
Axa
France
$2.44M +$1.5M +98,700 +153%
First Trust Advisors
46
First Trust Advisors
Illinois
$2.37M +$1.34M +88,230 +125%
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$2.35M +$2.39M +157,641 New
Russell Investments Group
48
Russell Investments Group
United Kingdom
$2.35M +$1.83M +120,608 +327%
State of New Jersey Common Pension Fund D
49
State of New Jersey Common Pension Fund D
New Jersey
$2.17M +$2.21M +145,640 New
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.15M -$75.1K -4,958 -3%

MD Hedge Fund Activity: Q1 2023 in Review

214 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2023, worth a combined $1.25B — up 4% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 28 closed out — a net gain of 7 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $22.1M. The largest seller was Starboard Value, exiting entirely with an estimated $81.3M sold.

  • 214 institutional investors held Pediatrix Medical (MD) as of Q1 2023, up from 209 in Q4 2022.
  • Funds reported $1.25B of Pediatrix Medical stock for Q1 2023, up 4% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q1 2023 and 28 closed out, a net change of +7 holders.
  • The largest Pediatrix Medical buyer in Q1 2023 was AllianceBernstein, an estimated $22.1M added.
  • The largest Pediatrix Medical seller in Q1 2023 was Starboard Value, an estimated $81.3M sold.

Based on aggregated 13F filings for Q1 2023.